Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending November 2012. The document serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific director transaction notification and does not contain financial performance data.
Material Changes
The filing details a transaction on November 9, 2012, involving Mr. P C Thomson and his connected person, Mrs. K Thomson. Through the Company's ShareReward Plan, they acquired Ordinary Shares at a price of 1369 pence per share. The transaction included:
- Acquisition of 2 Ordinary Shares under the personal contribution element.
- Acquisition of 2 Ordinary Shares under the matching element (Company contribution).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document strictly reports on the share transaction in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).
Key Facts for Investor Verification
- Transaction Date: November 9, 2012.
- Share Price: 1369 pence per Ordinary Share.
- Parties Involved: Mr. P C Thomson and Mrs. K Thomson (Connected Person).
- Total Shares Acquired: 4 Ordinary Shares (2 personal, 2 company match).
- Notification Date: November 12, 2012.